Component: (Network and Table)
Network
00500 - Statement - Consolidated Statements of Cash Flows
(http://www.catabasis.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001454789 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Operating activities
 
 
 
Net loss
(36,060,000) 
(32,630,000) 
(21,884,000) 
Reconciliation of net loss to net cash used in operating activities:
 
 
 
Depreciation and amortization
395,000  
202,000  
248,000  
Stock-based compensation expense
2,160,000  
1,658,000  
897,000  
Accretion of discount/premium on investment securities
148,000  
  
Non-cash interest expense
277,000  
293,000  
74,000  
Gain on the sale of fixed assets
(52,000) 
  
Changes in assets and liabilities:
 
 
 
Prepaid expenses and other current assets
(229,000) 
(450,000) 
(208,000) 
Other assets
 
2,000  
 
Accounts payable
77,000  
196,000  
481,000  
Accrued expenses
418,000  
954,000  
8,000  
Deferred rent
8,000  
(18,000) 
(28,000) 
Net cash used in operating activities
(32,858,000) 
 
(29,793,000) 
 
(20,412,000) 
 
Investing activities
 
 
 
Purchases of available-for-sale securities
(45,539,000) 
 
(4,976,000) 
Sales and maturities of available-for-sale securities
30,456,000  
 
4,976,000  
Purchases of property and equipment
(459,000) 
(421,000) 
(228,000) 
Sale of property and equipment
52,000  
  
Net cash used in investing activities
(15,490,000) 
 
(421,000) 
 
(228,000) 
 
Financing activities
 
 
 
Proceeds from initial public offering, net of issuance costs
 
61,744,000  
 
Proceeds from issuance of preferred stock, net of issuance costs
 
12,331,000  
 
Proceeds from registered direct offering, net of issuance costs
10,603,000  
  
Proceeds from at-the-market offering, net of issuance costs
1,391,000  
  
Proceeds from exercise of common stock options and warrants
503,000  
91,000  
118,000  
Proceeds from borrowing
 
5,000,000  
5,000,000  
Payments on borrowing
(3,333,000) 
(833,000) 
 
Debt issuance costs
 
(7,000) 
(284,000) 
Net cash provided by financing activities
9,164,000  
 
78,326,000  
 
4,834,000  
 
Net (decrease) increase in cash and cash equivalents
(39,184,000) 
 
48,112,000  
 
(15,806,000) 
 
Cash and cash equivalents, beginning of period
62,780,000  
14,668,000  
30,474,000  
Cash and cash equivalents, end of period
23,596,000  
 
62,780,000  
 
14,668,000  
 
Supplemental disclosure of cash flow information
 
 
 
Cash paid for interest
582,000  
684,000  
100,000  
Non-cash financing activities
 
 
 
Warrants for the purchase of series B preferred stock issued in conjunction with credit facility
 
107,000  
110,000  
Initial public offering costs in accounts payable and accrued liabilities
 
(492,000) 
492,000  
Reclassification of deferred IPO costs from non-current assets to additional paid-in capital
 
1,787,000  
 
Reclassification of warrant liability to additional paid-in capital
 
206,000